EP 1596848 A1 20051123 - USE OF 1-(2-CHLOROETHYL)-1-NITROSO-3-(2-HYDROXYETHYL)-UREA FOR THE TREATMENT OF PANCREATIC CANCER, LYMPHOMA, HEAD AND NECK TUMORS
Title (en)
USE OF 1-(2-CHLOROETHYL)-1-NITROSO-3-(2-HYDROXYETHYL)-UREA FOR THE TREATMENT OF PANCREATIC CANCER, LYMPHOMA, HEAD AND NECK TUMORS
Title (de)
VERWENDUNG VON 1-(2-CHLORETHYL)-1-NITROSO-3-(2-HYDROXYETHYL)-UREA ZUR BEHANDLUNG VON PANKREASKARZINOMEN, LYMPHOMEN, KOPF- UND HALTUMOREN
Title (fr)
UTILISATION DU COMPOSE 1-(2-CHLOROETHYL)-1-NITROSO-3-(2-HYDROXYETHYL)-UREE POUR TRAITER DES CARCINOMES PANCREATIQUES, LYMPHOMES, TUMEURS DE LA TETE ET DU COU
Publication
Application
Priority
- EP 2004001875 W 20040225
- DE 10307928 A 20030225
Abstract (en)
[origin: WO2004075887A1] The invention relates to the use of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)-urea (henceforth also called HECNU ) for the treatment of pancreatic cancer, soft-tissue sarcoma, testicular tumors, lymphoma, thymoma, Wilm's tumor, renal carcinoma, melanoma, lung cancer, intracerebral metastases, tumors in the head and neck region, and mammary carcinoma.
IPC 1-7
IPC 8 full level
A61K 31/17 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 31/17 (2013.01 - EP US); A61P 35/00 (2017.12 - EP)
Citation (search report)
See references of WO 2004075887A1
Citation (examination)
PREISS, DORNOFF, HAGMANN, SCHMIEDER: "ONKOLOGIE", 2002, ZUCKERSCHWERDT VERLAG GMBH
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004075887 A1 20040910; CA 2555746 A1 20040910; DE 10307928 A1 20040916; EP 1596848 A1 20051123; JP 2006518722 A 20060817; US 2006025484 A1 20060202
DOCDB simple family (application)
EP 2004001875 W 20040225; CA 2555746 A 20040225; DE 10307928 A 20030225; EP 04714277 A 20040225; JP 2006501954 A 20040225; US 21031305 A 20050824